Acumen Pharmaceuticals (ABOS) Other Non-Current Assets (2021 - 2026)
Acumen Pharmaceuticals recorded quarterly Other Non-Current Assets of $231000.0 in Q1 2026, little changed quarter-over-quarter from $231000.0 in Q4 2025, and little changed year-over-year from $232000.0 in Q1 2025.
Acumen Pharmaceuticals' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $231000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed 0.43% year-over-year to $231000.0; the TTM figure through Mar 2026 stood at $231000.0 (changed 0.43% YoY), while the FY2025 annual figure was $231000.0, down 52.47% from the prior year.
- Other Non-Current Assets came in at $231000.0 for Q1 2026 at Acumen Pharmaceuticals, roughly flat from $231000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $486000.0 in Q4 2024 to a low of $79000.0 in Q1 2022.
- A 5-year average of $223933.3 and a median of $232000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets surged 715.38% in 2022 and tumbled 52.47% in 2025, its largest moves.
- Acumen Pharmaceuticals' Other Non-Current Assets stood at $106000.0 in 2022, then surged by 119.81% to $233000.0 in 2023, then surged by 108.58% to $486000.0 in 2024, then sank by 52.47% to $231000.0 in 2025, then changed by 0.0% to $231000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $231000.0, $231000.0, and $232000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | 231,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231,000.00 |
| Dec 31, 2025 | 231,000.00 |
| Sep 30, 2025 | 232,000.00 |
| Jun 30, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 233,000.00 |
| Sep 30, 2023 | 189,000.00 |
| Jun 30, 2023 | 208,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Jun 30, 2022 | 106,000.00 |
| Mar 31, 2022 | 79,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 13,000.00 |